Coloplast Net Income 2014-2025 | CLPBY
Coloplast annual/quarterly net income history and growth rate from 2014 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Coloplast net income for the quarter ending September 30, 2025 was $0.138B, a 28.56% decline year-over-year.
- Coloplast net income for the twelve months ending September 30, 2025 was $0.538B, a 26.69% decline year-over-year.
- Coloplast annual net income for 2025 was $0.538B, a 26.69% decline from 2024.
- Coloplast annual net income for 2024 was $0.735B, a 7.1% increase from 2023.
- Coloplast annual net income for 2023 was $0.686B, a 0.04% decline from 2022.
|
Coloplast Annual Net Income (Millions of US $) |
|
|---|---|
| 2025 | $538 |
| 2024 | $735 |
| 2023 | $686 |
| 2022 | $686 |
| 2021 | $775 |
| 2020 | $630 |
| 2019 | $585 |
| 2018 | $614 |
| 2017 | $564 |
| 2016 | $469 |
| 2015 | |
|
Coloplast Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $138 |
| 2025-06-30 | $122 |
| 2025-03-31 | $129 |
| 2024-12-31 | $149 |
| 2024-09-30 | $193 |
| 2024-06-30 | $184 |
| 2024-03-31 | $182 |
| 2023-12-31 | $175 |
| 2023-09-30 | $179 |
| 2023-06-30 | $186 |
| 2023-03-31 | $166 |
| 2022-12-31 | $155 |
| 2022-09-30 | $169 |
| 2022-06-30 | $184 |
| 2022-03-31 | $148 |
| 2021-12-31 | $186 |
| 2021-09-30 | $207 |
| 2021-06-30 | $203 |
| 2021-03-31 | $183 |
| 2020-12-31 | $182 |
| 2020-09-30 | $164 |
| 2020-06-30 | $147 |
| 2020-03-31 | $158 |
| 2019-12-31 | $162 |
| 2019-09-30 | $117 |
| 2019-06-30 | $161 |
| 2019-03-31 | $155 |
| 2018-12-31 | $152 |
| 2018-09-30 | $163 |
| 2018-06-30 | $152 |
| 2018-03-31 | $152 |
| 2017-12-31 | $148 |
| 2017-09-30 | $159 |
| 2017-06-30 | $135 |
| 2017-03-31 | $134 |
| 2016-12-31 | $137 |
| 2016-09-30 | |
| 2015-12-31 | $121 |
| 2014-06-30 | $106 |
| 2014-03-31 | $-4 |
| 2013-12-31 | $142 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $17.488B | $4.130B |
| Coloplast A/S engages in the development and sale of intimate healthcare products and services principally in Denmark, the United States, the United Kingdom, France and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology and Advanced Wound Care segments. Coloplast A/S is based in Humleb?k, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $198.062B | 23.05 |
| Intuitive Surgical (ISRG) | United States | $176.187B | 67.96 |
| IDEXX Laboratories (IDXX) | United States | $51.802B | 49.63 |
| Edwards Lifesciences (EW) | United States | $46.035B | 30.99 |
| Alcon (ALC) | Switzerland | $39.268B | 26.46 |
| IQVIA Holdings (IQV) | United States | $30.174B | 16.30 |
| Mettler-Toledo (MTD) | United States | $28.306B | 32.55 |
| DexCom (DXCM) | United States | $26.580B | 36.64 |
| STERIS (STE) | Ireland | $23.878B | 24.15 |
| Waters (WAT) | United States | $19.603B | 25.07 |
| Hologic (HOLX) | United States | $16.763B | 17.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.540B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.942B | 11.56 |
| Penumbra (PEN) | United States | $13.247B | 93.18 |
| Globus Medical (GMED) | United States | $11.813B | 24.79 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.254B | 23.24 |
| Sysmex ADR (SSMXY) | Japan | $6.295B | 20.00 |
| Glaukos (GKOS) | United States | $6.262B | 0.00 |
| Teleflex (TFX) | United States | $4.727B | 7.53 |
| TransMedics (TMDX) | United States | $4.555B | 53.97 |
| LivaNova (LIVN) | United Kingdom | $3.627B | 19.60 |
| Integer Holdings (ITGR) | United States | $3.055B | 14.34 |
| Veracyte (VCYT) | United States | $2.845B | 32.42 |
| Elekta AB (EKTAY) | Sweden | $2.250B | 21.05 |
| Nihon Kohden (NHNKY) | Japan | $2.036B | 22.47 |
| UFP Technologies (UFPT) | United States | $2.032B | 26.83 |
| Alphatec Holdings (ATEC) | United States | $2.001B | 0.00 |
| Artivion (AORT) | United States | $1.900B | 87.17 |
| Pulse Biosciences (PLSE) | United States | $1.711B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.593B | 0.00 |
| AxoGen (AXGN) | United States | $1.564B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.333B | 0.00 |
| IRadimed (IRMD) | United States | $1.311B | 58.90 |
| OPKO Health (OPK) | United States | $0.960B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.871B | 4.72 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.702B | 14.00 |
| SiBone (SIBN) | United States | $0.661B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.632B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.622B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.617B | 35.87 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.535B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.504B | 13.13 |
| NeuroPace (NPCE) | United States | $0.485B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.469B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.432B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.380B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.335B | 55.88 |
| RxSight (RXST) | United States | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.292B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.286B | 0.00 |
| 908 Devices (MASS) | United States | $0.239B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.236B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.186B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.165B | 0.00 |
| CVRx (CVRX) | United States | $0.159B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.134B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.129B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.127B | 0.00 |
| Neuronetics (STIM) | United States | $0.123B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 0.00 |
| Solana (HSDT) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| DarioHealth (DRIO) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.065B | 0.00 |
| Accuray (ARAY) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.016B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |